Thompson Tommy G
SEC Form 4 insider trading activity
Thompson Tommy G has filed 5 SEC Form 4 filings (11 transaction rows) across 2 companies, including UTHR, TXMD, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Mar 26, 2026.
On the most recent filing, Thompson Tommy G is listed as Director at UNITED THERAPEUTICS Corp. Inside the rolling window, Thompson Tommy G reported 1 open-market purchase totaling $14K in TXMD and 3 open-market sales totaling $2.5M in UTHR. The largest disclosed transaction in the window is a sale of 2,000 UTHR shares on Mar 26, 2026, worth $1.1M.
Companies traded
Other insiders at UTHR
Insider Buying
$14K
reported purchases (SEC code P)
Insider Selling
$2.5M
reported sales (SEC code S)
Companies
2
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 10, 2025 | UTHR | Sale | $1.8M |
Frequently asked questions
How many SEC Form 4 filings has Thompson Tommy G made?
Thompson Tommy G has filed 5 SEC Form 4 filings (11 transaction rows) across 2 companies, including UTHR, TXMD since 2025.
Which companies does Thompson Tommy G trade?
Thompson Tommy G has filed SEC Form 4 disclosures for 2 companies, including UTHR, TXMD.
When was Thompson Tommy G's most recent SEC Form 4 filing?
Thompson Tommy G's most recent SEC Form 4 filing on Tracefour is dated Mar 26, 2026.
What is Thompson Tommy G's total buy and sell value in the current window?
Inside the rolling retention window, Thompson Tommy G bought $14K and sold $2.5M based on SEC Form 4 filings.
What was Thompson Tommy G's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,000 UTHR shares on 2026-03-26, worth $1.1M, per SEC Form 4 filings.